Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,040.00
Bid: 3,039.00
Ask: 3,041.00
Change: 10.00 (0.33%)
Spread: 2.00 (0.066%)
Open: 3,027.00
High: 3,051.00
Low: 2,997.00
Prev. Close: 3,030.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio update and Capital Markets Seminar

23 Sep 2020 07:00

RNS Number : 7923Z
3i Group PLC
23 September 2020
 

 

Press release

23 September 2020

 

3i Group plc

Update on the portfolio and Capital Markets Seminar

 

3i Group plc ("3i" or "the Group") will be holding a Capital Markets Seminar via webcast today, involving presentations on our approach to ESG and responsible investment, as well as on Evernex and SaniSure, two of our recent Private Equity Investments. In addition, Simon Borrows, our Chief Executive, will provide an update on the portfolio, the key elements of which are outlined below. The seminar will start at 14.00 and the joining details are provided at the end of this press release. The presentation materials and a recording of the webcast will also be made available on our website.

We have now completed our September semi-annual portfolio company reviews for Private Equity, Infrastructure and Scandlines, which have reinforced our belief in the resilience and strength of earnings performance in the significant majority of our investments. The automotive sector remains challenged, and public health policy has prolonged the uncertainty for the travel sector. However, we continue to see strong momentum in portfolio companies exposed to medical technology and personal care products and very good recovery in our retail businesses, particularly in online, and of course in Action.

Action's impressive performance has continued with sales, EBITDA and cash generation above expectations for P7 (July), P8 (August) and P9 (September) to date. YTD sales at over €3.7 billion have now recovered to be approximately 8% ahead of last year with strong trading continuing across all geographies. We expect LTM EBITDA to the end of P9 to be approximately €575 million compared to €506 million at September last year and €491 million at the end of P4 this year. Cash generation has continued to be strong with a current cash balance of over €625 million after a €51 million repayment of the RCF. Action has now opened 88 stores in 2020 including its first five stores in the Czech Republic. Initial trading in the Czech Republic has been significantly ahead of expectations.

A live webcast of the seminar will be available at 14.00. To register for the webcast, please visit www.3i.com/investor-relations/capital-markets-presentations/2020.

 

- Ends-

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

Notes to editors:

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDCXSDDGGD
Date   Source Headline
31st Jul 20154:02 pmRNSDirector/PDMR Shareholding
30th Jul 20159:45 amRNSDirector/PDMR Shareholding
30th Jul 20159:42 amRNSDirector/PDMR Shareholding
29th Jul 20151:36 pmRNSDirector/PDMR Shareholding
29th Jul 20157:00 amRNSFY2016 Q1 performance update
7th Jul 201510:20 amRNSPortfolio Update
30th Jun 20152:53 pmRNSTotal Voting Rights
30th Jun 20152:51 pmRNSDirector/PDMR Shareholding
26th Jun 20159:57 amRNSDirector/PDMR Shareholding
25th Jun 20152:51 pmRNSResult of AGM
25th Jun 20152:48 pmRNSDoc re. AGM Resolutions
25th Jun 20157:00 amRNSAGM
15th Jun 20158:00 amRNSCapital Markets seminar
10th Jun 20153:39 pmRNSDirector/PDMR Shareholding
9th Jun 201511:27 amRNSBlocklisting Interim Review
4th Jun 20152:01 pmRNSDirector/PDMR Shareholding
3rd Jun 201512:43 pmRNSDirector/PDMR Shareholding
29th May 20153:43 pmRNSTotal Voting Rights
29th May 20153:42 pmRNSDirector/PDMR Shareholding
27th May 20153:46 pmRNSDTR 6.3.5
27th May 201510:50 amRNSDoc re. 2015 Annual Report and Accounts
14th May 20157:00 amRNSFinancial results for the year to 31 March 2015
30th Apr 20154:00 pmRNSTotal Voting Rights
30th Apr 20153:59 pmRNSDirector/PDMR Shareholding
13th Apr 201511:01 amRNSDirectorate Change
8th Apr 20151:10 pmRNSPortfolio Update
31st Mar 20153:52 pmRNSTotal Voting Rights
31st Mar 20153:51 pmRNSDirector/PDMR Shareholding
26th Mar 20152:41 pmRNSDirector/PDMR Shareholding
10th Mar 201511:45 amRNSDirector/PDMR Shareholding
2nd Mar 20159:46 amRNSTotal Voting Rights
27th Feb 20153:28 pmRNSDirector/PDMR Shareholding
17th Feb 20152:28 pmRNSDirector/PDMR Shareholding
6th Feb 20151:57 pmRNSDirector/PDMR Shareholding
30th Jan 20154:25 pmRNSTotal Voting Rights
30th Jan 20154:24 pmRNSDirector/PDMR Shareholding
29th Jan 201510:58 amRNSDirector/PDMR Shareholding
29th Jan 20157:00 amRNSQ3 performance update
13th Jan 20152:40 pmRNSDirector/PDMR Shareholding
13th Jan 201510:46 amRNSDirector/PDMR Shareholding
7th Jan 20152:35 pmRNSPortfolio Update
31st Dec 201412:29 pmRNSTotal Voting Rights
31st Dec 201412:28 pmRNSDirector/PDMR Shareholding
9th Dec 20142:04 pmRNSBlocklisting Interim Review
5th Dec 201410:28 amRNSDirector/PDMR Shareholding
28th Nov 20143:26 pmRNSTotal Voting Rights
28th Nov 20143:26 pmRNSDirector/PDMR Shareholding
17th Nov 20143:10 pmRNSDirector/PDMR Shareholding
14th Nov 201410:52 amRNSDirector/PDMR Shareholding
14th Nov 201410:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.